RxDoctor Payments Data

Tammi Jones

Family · Belleville, ILNPI 1902273717

Payments from drug & device makers

$756in general payments, 2019–2025

Across 35 payments — averaging $21.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$309
  • Fresenius USA Marketing, Inc.$102
  • Scpharmaceuticals Inc.$61
  • AstraZeneca$61
  • Novo Nordisk$47
  • Bayer$39
  • plus $137 from 6 others

What the payments were for

  • Food & beverage$756100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$756 in reported general payments places this provider in the 65th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$75,801
Medicare patients
170
Services billed
400

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VelphoroSucroferric Oxyhydroxide32$95,959
Sevelamer Carbonate160$43,946
FarxigaDapagliflozin Propanediol36$27,621
LokelmaSodium Zirconium Cyclosilicate21$24,173
EliquisApixaban17$11,831
ProsolParenteral Amino Acid 20% No.154$10,723
Hydralazine Hcl70$1,863
Calcium Acetate29$1,718
Calcitriol48$896
Clonidine Hcl48$833
Atorvastatin Calcium48$767
Carvedilol77$696
Midodrine Hcl13$677
Amlodipine Besylate79$591
Metolazone16$590

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Fresenius USA Marketing, Inc.Velphoro$102$95,95932 claims
AstraZenecaFarxiga, Lokelma$61$51,79457 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 4,941 family providers in Illinois.

Other family in Belleville

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →